Huadong Medicine (China) Performance
| 000963 Stock | 35.95 0.24 0.66% |
On a scale of 0 to 100, Huadong Medicine holds a performance score of 12. The company retains a Market Volatility (i.e., Beta) of 0.26, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Huadong Medicine's returns are expected to increase less than the market. However, during the bear market, the loss of holding Huadong Medicine is expected to be smaller as well. Please check Huadong Medicine's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Huadong Medicine's current trending patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Huadong Medicine Co are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Huadong Medicine sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0259 | Payout Ratio 0.5225 | Last Split Factor 1.2:1 | Forward Dividend Rate 0.93 | Ex Dividend Date 2024-09-20 |
1 | Huadong Medicine Co., Ltds largest shareholders are private companies who were rewarded as market cap surged CN2.7b last week - Simply Wall St | 10/09/2024 |
| Begin Period Cash Flow | 3.4 B |
Huadong |
Huadong Medicine Relative Risk vs. Return Landscape
If you would invest 2,880 in Huadong Medicine Co on September 24, 2024 and sell it today you would earn a total of 715.00 from holding Huadong Medicine Co or generate 24.83% return on investment over 90 days. Huadong Medicine Co is generating 0.4033% of daily returns and assumes 2.6013% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than Huadong, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Huadong Medicine Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Huadong Medicine's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Huadong Medicine Co, and traders can use it to determine the average amount a Huadong Medicine's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.155
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 000963 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.6 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Huadong Medicine is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Huadong Medicine by adding it to a well-diversified portfolio.
Huadong Medicine Fundamentals Growth
Huadong Stock prices reflect investors' perceptions of the future prospects and financial health of Huadong Medicine, and Huadong Medicine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Huadong Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0671 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 60.7 B | ||||
| Shares Outstanding | 1.75 B | ||||
| Price To Book | 2.86 X | ||||
| Price To Sales | 1.49 X | ||||
| Revenue | 40.62 B | ||||
| Gross Profit | 12.03 B | ||||
| EBITDA | 4.62 B | ||||
| Net Income | 2.84 B | ||||
| Total Debt | 822.38 M | ||||
| Book Value Per Share | 12.64 X | ||||
| Cash Flow From Operations | 3.93 B | ||||
| Earnings Per Share | 1.83 X | ||||
| Total Asset | 33.51 B | ||||
| Retained Earnings | 15.69 B | ||||
About Huadong Medicine Performance
By analyzing Huadong Medicine's fundamental ratios, stakeholders can gain valuable insights into Huadong Medicine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Huadong Medicine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Huadong Medicine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Huadong Medicine is entity of China. It is traded as Stock on SHE exchange.Things to note about Huadong Medicine performance evaluation
Checking the ongoing alerts about Huadong Medicine for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Huadong Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Huadong Medicine is unlikely to experience financial distress in the next 2 years | |
| About 58.0% of the company shares are owned by insiders or employees |
- Analyzing Huadong Medicine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Huadong Medicine's stock is overvalued or undervalued compared to its peers.
- Examining Huadong Medicine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Huadong Medicine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Huadong Medicine's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Huadong Medicine's stock. These opinions can provide insight into Huadong Medicine's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Huadong Stock analysis
When running Huadong Medicine's price analysis, check to measure Huadong Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Huadong Medicine is operating at the current time. Most of Huadong Medicine's value examination focuses on studying past and present price action to predict the probability of Huadong Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Huadong Medicine's price. Additionally, you may evaluate how the addition of Huadong Medicine to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |